| COVID-19 severity and mortality in patients with CLL: an update of the international ERIC and Campus CLL study T Chatzikonstantinou, A Kapetanakis, L Scarfò, G Karakatsoulis, D Allsup, ... Leukemia 35 (12), 3444-3454, 2021 | 76 | 2021 |
| Danazol therapy for the anemia of myelofibrosis: assessment of efficacy with current criteria of response and long-term results F Cervantes, IM Isola, A Alvarez-Larrán, JC Hernández-Boluda, ... Annals of hematology 94, 1791-1796, 2015 | 67 | 2015 |
| Clinical characteristics, prognosis and treatment of myelofibrosis patients with severe thrombocytopenia JC Hernández‐Boluda, JG Correa, A Alvarez‐Larrán, F Ferrer‐Marín, ... British journal of haematology 181 (3), 397-400, 2018 | 34 | 2018 |
| Imatinib dose reduction in patients with chronic myeloid leukemia in sustained deep molecular response F Cervantes, JG Correa, I Pérez, V García-Gutiérrez, S Redondo, ... Annals of hematology 96, 81-85, 2017 | 32 | 2017 |
| Performance of the myelofibrosis secondary to PV and ET-prognostic model (MYSEC-PM) in a series of 262 patients from the Spanish registry of myelofibrosis JC Hernández-Boluda, A Pereira, JG Correa, A Alvarez-Larrán, ... Leukemia 32 (2), 553-555, 2018 | 30 | 2018 |
| Results of ARI-0001 CART19 cells in patients with chronic lymphocytic leukemia and Richter’s transformation V Ortiz-Maldonado, G Frigola, M Español-Rego, O Balagué, ... Frontiers in Oncology 12, 828471, 2022 | 29 | 2022 |
| Predictive factors for anemia response to erythropoiesis‐stimulating agents in myelofibrosis JC Hernández‐Boluda, JG Correa, R García‐Delgado, J Martínez‐López, ... European journal of haematology 98 (4), 407-414, 2017 | 28 | 2017 |
| Long-term results of prednisone treatment for the anemia of myelofibrosis JC Hernandez-Boluda, A Martínez-Trillos, V García-Gutiérrez, ... Leukemia & lymphoma 57 (1), 120-124, 2016 | 24 | 2016 |
| Genomic characterization in triple-negative primary myelofibrosis and other myeloid neoplasms with bone marrow fibrosis A Alvarez-Larrán, M López-Guerra, M Rozman, JG Correa, ... Annals of hematology 98 (10), 2319-2328, 2019 | 22 | 2019 |
| Alleviating anemia and thrombocytopenia in myelofibrosis patients F Cervantes, JG Correa, JC Hernandez-Boluda Expert Review of Hematology 9 (5), 489-496, 2016 | 16 | 2016 |
| Clinicobiological characteristics and outcomes of patients with t-cell large granular lymphocytic leukemia and chronic lymphoproliferative disorder of natural killer cells from … A Rivero, P Mozas, L Jiménez, M López-Guerra, D Colomer, A Bataller, ... Cancers 13 (15), 3900, 2021 | 14 | 2021 |
| Predicting survival after allogeneic hematopoietic cell transplantation in myelofibrosis: performance of the Myelofibrosis Transplant Scoring System (MTSS) and development of a … JC Hernández-Boluda, A Pereira, A Alvarez-Larran, AA Martín, ... Biology of Blood and Marrow Transplantation 26 (12), 2237-2244, 2020 | 14 | 2020 |
| At-home autologous stem cell transplantation in multiple myeloma with and without G-CSF administration: a comparative study N Martínez-Cibrian, L Magnano, G Gutiérrez-García, X Andrade, ... Bone Marrow Transplantation 51 (4), 593-595, 2016 | 13 | 2016 |
| Prognostic risk models for transplant decision-making in myelofibrosis JC Hernández-Boluda, A Pereira, JG Correa, A Alvarez-Larrán, ... Annals of hematology 97, 813-820, 2018 | 12 | 2018 |
| Clinico-biological characteristics of patients with myelofibrosis: an analysis of 1,000 cases from the Spanish Registry of Myelofibrosis I Pastor-Galán, JC Hernández-Boluda, JG Correa, A Alvarez-Larrán, ... Medicina Clínica (English Edition) 155 (4), 152-158, 2020 | 11 | 2020 |
| Prevalence and prognosis implication of MYD88 L265P mutation in IgM monoclonal gammopathy of undetermined significance and smouldering Waldenstrom macroglobulinaemia. JG Correa, MT Cibeira, N Tovar, I Isola, F Pedrosa, T Diaz, E Lozano, ... British Journal of Haematology 179 (5), 2017 | 10 | 2017 |
| A low lymphocyte-to-monocyte ratio is an independent predictor of poorer survival and higher risk of histological transformation in follicular lymphoma P Mozas, A Rivero, A Rivas-Delgado, F Nadeu, G Clot, JG Correa, ... Leukemia & Lymphoma 62 (1), 104-111, 2021 | 9 | 2021 |
| Results of ARI‐0001 CART19 cell therapy in patients with relapsed/refractory CD19‐positive acute lymphoblastic leukemia with isolated extramedullary disease V Ortiz‐Maldonado, A Alonso‐Saladrigues, M Español‐Rego, ... American Journal of Hematology 97 (6), 731-739, 2022 | 8 | 2022 |
| Prognostic ability of five clinical risk scores in follicular lymphoma: A single‐center evaluation P Mozas, A Rivero, A Rivas‐Delgado, JG Correa, M Condom, F Nadeu, ... Hematological Oncology 39 (5), 639-649, 2021 | 8 | 2021 |
| Prognostic impact of MYD88 and CXCR4 mutations assessed by droplet digital polymerase chain reaction in IgM monoclonal gammopathy of undetermined … DF Moreno, M López‐Guerra, S Paz, A Oliver‐Caldés, MP Mena, ... British Journal of Haematology 200 (2), 187-196, 2023 | 7 | 2023 |
